Skip to content

Study · Not a test of the peptide alone · 2016

2 results

Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity.

Deigin V, Ksenofontova O, Khrushchev A, Yatskin O, Goryacheva A, Ivanov V

ChemMedChem26 Jul 2016Cited by 9 (Europe PMC)

PMID27457274 (opens in a new tab)PMCIDPMC5095862 (opens in a new tab)DOI10.1002/cmdc.201600157 (opens in a new tab)PepBankPUB-27457274
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymogen (oglufanide).

  1. 01AnimalNot a test of Thymogen (oglufanide) aloneAnimal study (in vivo)Activity measurement

    In intact mice, three of five synthetic analogues of thymogen and stemokin showed high hemostimulatory activity.

    In plain wordsIn mice, three of five thymogen and stemokin analogues showed high blood-cell-stimulating activity.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseHemostimulatory activity
    Study

    mousen: not reported in source

    intact mice
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Of the five synthesized analogues, three demonstrated high hemostimulatory activity in vivo on intact mice and on ex vivo irradiated bone marrow cells.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  2. 02LabNot a test of Thymogen (oglufanide) aloneEx vivo tissueActivity measurement

    In irradiated bone marrow cells, three of five synthetic analogues of thymogen and stemokin showed high hemostimulatory activity.

    In plain wordsIn lab tests, three of five thymogen and stemokin analogues showed high blood-cell-stimulating activity in irradiated bone marrow cells.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseHemostimulatory activity
    Study

    mousen: not reported in source

    irradiated bone marrow cells
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Of the five synthesized analogues, three demonstrated high hemostimulatory activity in vivo on intact mice and on ex vivo irradiated bone marrow cells.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.